| CRISPR-Cas9 for cancer therapy: Opportunities and challenges M Chen, A Mao, M Xu, Q Weng, J Mao, J Ji Cancer letters 447, 48-55, 2019 | 205 | 2019 |
| The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma B Tang, J Zhu, J Li, K Fan, Y Gao, S Cheng, C Kong, L Zheng, F Wu, ... Cell Communication and Signaling 18, 1-18, 2020 | 172 | 2020 |
| Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE C Kong, Z Zhao, W Chen, X Lv, G Shu, M Ye, J Song, X Ying, Q Weng, ... European radiology 31, 7500-7511, 2021 | 88 | 2021 |
| Targeted xCT‐mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti‐PD‐1/L1 response B Tang, J Zhu, Y Wang, W Chen, S Fang, W Mao, Z Xu, Y Yang, Q Weng, ... Advanced Science 10 (2), 2203973, 2023 | 84 | 2023 |
| miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression M Chen, L Wu, J Tu, Z Zhao, X Fan, J Mao, Q Weng, X Wu, L Huang, M Xu, ... EBioMedicine 35, 142-154, 2018 | 83 | 2018 |
| Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells X Zhang, M Chen, P Zou, K Kanchana, Q Weng, W Chen, P Zhong, J Ji, ... BMC cancer 15, 1-11, 2015 | 81 | 2015 |
| Efficacy and safety of TACE combined with sorafenib plus immune checkpoint inhibitors for the treatment of intermediate and advanced TACE-refractory hepatocellular carcinoma: a … L Zheng, S Fang, F Wu, W Chen, M Chen, Q Weng, X Wu, J Song, Z Zhao, ... Frontiers in molecular biosciences 7, 609322, 2021 | 71 | 2021 |
| CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway Z Zhao, J Song, B Tang, S Fang, D Zhang, L Zheng, F Wu, Y Gao, C Chen, ... Journal of Experimental & Clinical Cancer Research 39, 1-16, 2020 | 69 | 2020 |
| Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma Q Weng, M Chen, M Li, YF Zheng, G Shao, W Fan, XM Xu, J Ji Journal of medical genetics 56 (1), 32-38, 2019 | 61 | 2019 |
| Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis B Tang, J Zhu, S Fang, Y Wang, R Vinothkumar, M Li, Q Weng, Y Yang, ... Free Radical Biology and Medicine 172, 312-329, 2021 | 59 | 2021 |
| Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation W Chen, P Zou, Z Zhao, Q Weng, X Chen, S Ying, Q Ye, Z Wang, J Ji, ... Oncotarget 7 (13), 16593, 2016 | 54 | 2016 |
| Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma C Lu, S Fang, Q Weng, X Lv, M Meng, J Zhu, L Zheng, Y Hu, Y Gao, X Wu, ... Cell Communication and Signaling 18 (1), 97, 2020 | 52 | 2020 |
| Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death B Tang, W Xu, Y Wang, J Zhu, H Wang, J Tu, Q Weng, C Kong, Y Yang, ... Clinical Immunology 232, 108872, 2021 | 51 | 2021 |
| Therapeutic potential of triptolide as an anti-inflammatory agent in dextran sulfate sodium-induced murine experimental colitis B Tang, J Zhu, B Zhang, F Wu, Y Wang, Q Weng, S Fang, L Zheng, ... Frontiers in immunology 11, 592084, 2020 | 49 | 2020 |
| Association between menopause and lumbar disc degeneration: an MRI study of 1,566 women and 1,382 men C Lou, H Chen, L Mei, W Yu, K Zhu, F Liu, Z Chen, G Xiang, M Chen, ... Menopause 24 (10), 1136-1144, 2017 | 48 | 2017 |
| Piperlongumine, a novel TrxR1 inhibitor, induces apoptosis in hepatocellular carcinoma cells by ROS-mediated ER stress Q Zhang, W Chen, X Lv, Q Weng, M Chen, R Cui, G Liang, J Ji Frontiers in pharmacology 10, 1180, 2019 | 45 | 2019 |
| Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells Z Liu, Y Sun, L Ren, Y Huang, Y Cai, Q Weng, X Shen, X Li, G Liang, ... BMC cancer 13, 1-9, 2013 | 44 | 2013 |
| LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1 J Tu, Z Zhao, M Xu, M Chen, Q Weng, J Ji Biomedicine & Pharmacotherapy 118, 109213, 2019 | 43 | 2019 |
| EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress Z Xu, Y Zhao, P Zhong, J Wang, Q Weng, Y Qian, J Han, C Zou, G Liang Oncotarget 8 (20), 32655, 2017 | 42 | 2017 |
| CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance M Xu, S Fang, J Song, M Chen, Q Zhang, Q Weng, X Fan, W Chen, X Wu, ... Cell death & disease 9 (10), 957, 2018 | 40 | 2018 |
